Finished Drugs
Nucleosides series
New inhibitors and intermediates
Cardiovascular&Antidiabetic API and intermediates
Anti-tumor and cancer API and intermediates
Antibiotics APIs and intermediates
Antipsychotic API and intermediates
Anti-virus API and intermediates
Dermopathic API and intermediates
Histamine API and intermediates
Gastrointestinal stromal API and intermediates
Vitamin Amino acids and nutraceuticals series
Steroid hormones and other intermediates
PVP Homopolymers and special chemicals
Pharmaceutical Excipients
XINXIANG BEST PHARMACEUTICAL CO.,LTD. Sales email：sales@bstpharm.com OEM email：research@bstpharm.com Purchase＆import email：purchase@bstpharm.com Tel：0086-373-6378323 Fax：0086-373-3809550 Website：www.bstpharm.com www.xxbestpharm.com Address：Hualan Road 509,Xinxiang City,Henan.China 45300
| No | Name | Standard | CAS NO | Remarks |
|---|---|---|---|---|
| N062 | 5-Methyl-2’- Methyoxyuridine | 99% | 55486-09-4 | Nucleosides series |
| N063 | 2’-Deoxy-2’-Fluorouridine | 99% | 784-71-4 | Nucleosides series |
| N064 | 2’-Deoxy-2’-Fluorocytidine | 99% | 10212-20-1 | Nucleosides series |
| N065 | Tetraacetylribofuranose | 99% | 13035-61-5 | Nucleosides series |
| N066 | 1,2,3-Triacetyl-5-Deoxy-D-Ribose | 99% | 62211-93-2 | Nucleosides series |
| N067 | 1-O-Acetyl-2,3,5-Tri-D-Benzoyl –β-D-Ribose | 99% | 6974-32-9 | Nucleosides series |
| N068 | 1-Chloro-3,5-Di-(p-Chlorobenzoyl)-2-Deoxy-D-Ribose | 99% | 3601-90-9 | Nucleosides series |
| N069 | Fluorosugar | 99% | 97614-43-2 | Nucleosides series |
| N070 | 1,3,5-Tri-O-benzoyl-D-ribofuranose | 99% | 22224-41-5 | Nucleosides series |
| N071 | Inosine | USP | 58-63-9 | Nucleosides series |
| N072 | Ribavirin | USP | 36791-04-5 | Nucleosides series |
| N073 | Citicoline Sodium | USP | 33818-15-4 | Nucleosides series |
| N074 | Citicoline | 99% | 987-78-0 | Nucleosides series |
| N075 | Acyclovir | USP | 59277-89-3 | Nucleosides series |
| N076 | S-Adenosylmethionine1,4-butanedisulfonate | USP | 101020-79-5 | Nucleosides series |
| N077 | Fludarabine phosphate | USP | 75607-67-9 | Nucleosides series |
| N078 | Cytarabine hydrochloride | USP | 69-74-9 | Nucleosides series |
| N079 | Clofarabine | USP | 123318-82-1 | Nucleosides series |
| N080 | Nelarabine | USP | 121032-29-9 | Nucleosides series |
| N081 | Capecitabine | USP | 154361-50-9 | Nucleosides series |
| N082 | 5-Iodo-2’-Deoxyuridine | USP | 54-42-2 | Nucleosides series |
| I001 | LCZ696 | 99.0% | 936623-90-4 | Heart drugs |
| I002 | Palbociclib or PD-0332991 | 99.0% | 827022-32-2 | ER-positive and HER2-negative breast cancer |
| I003 | evolocumab or AMG145 | 99.0% | 1256937-27-5 | hyperlipidemia |
| I004 | Elbasvir (MK-8742) | 99.0% | 1444832-51-2 | treatment of hepatitis C |
| I005 | Insulin glargine | 99.0% | 160337-95-1 | pulmonary hypertension |
| I006 | Secukinumab | 99.0% | 875356-43-7 1229022-83-6 | human monoclonal antibody |
| I007 | ABT-199 | 99.0% | 1257044-40-8 | Bcl-2-selective inhibitor |
| I008 | Brexpiprazole | 99.9% | 913611-97-9 | treatment of depression |
| I009 | selexipag | 99.0% | 475086-01-2 | Pulmonan, schizophrenry Hypertension |